Recently, the 250,000 tons/year cyclohexane dehydrogenation unit (Phase I) of Guangxi Hengyi's 1.2 million tons/year caprolactam-polyamide integrated and supporting project, which utilizes technology and catalysts provided by China National Chemical Engineering Research Institute, was designed by Saiding Company and constructed by Sanhuajian, successfully completed its first feed-in operation. The entire process was smoothly integrated, and qualified products were continuously produced with stable unit operation.

PriceSeek Analysis:
Caprolactam, Bull-Bear Score: -2
The successful commissioning of Guangxi Hengyi's 1.2 million tons/year caprolactam plant, achieving full-process integration and continuous production of qualified products, significantly increases market supply. The increased supply is expected to ease supply-demand tensions, putting downward pressure on spot prices, thus rating it as a significant bearish factor.

Benzene, Bull-Bear Score: 2
Following the commissioning of the new plant, demand for benzene, a key raw material in caprolactam production, is expected to rise. Increased demand may drive up spot prices. Additionally, based on benzene futures market data, recent contracts such as 2603 closed at 5,584 yuan/ton (up 21 yuan) and 2604 closed at 5,638 yuan/ton (up 31 yuan), indicating strong upward momentum in the market. Rising demand will further support the upward trend in futures prices, thus rating it as a significant bullish factor.